CA2054017A1 - Antidiarrheal compositions - Google Patents

Antidiarrheal compositions

Info

Publication number
CA2054017A1
CA2054017A1 CA002054017A CA2054017A CA2054017A1 CA 2054017 A1 CA2054017 A1 CA 2054017A1 CA 002054017 A CA002054017 A CA 002054017A CA 2054017 A CA2054017 A CA 2054017A CA 2054017 A1 CA2054017 A1 CA 2054017A1
Authority
CA
Canada
Prior art keywords
loperamide hydrochloride
antidiarrheal
syrup
saccharide
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002054017A
Other languages
English (en)
French (fr)
Inventor
Toshiaki Kurazumi
Hiroyuki Mizuno
Katsumi Imamori
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2054017A1 publication Critical patent/CA2054017A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002054017A 1990-10-24 1991-10-23 Antidiarrheal compositions Abandoned CA2054017A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP286458/1990 1990-10-24
JP2286458A JP2711759B2 (ja) 1990-10-24 1990-10-24 止瀉剤組成物

Publications (1)

Publication Number Publication Date
CA2054017A1 true CA2054017A1 (en) 1992-04-25

Family

ID=17704653

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002054017A Abandoned CA2054017A1 (en) 1990-10-24 1991-10-23 Antidiarrheal compositions

Country Status (8)

Country Link
US (2) US5182112A (https=)
EP (1) EP0482580B1 (https=)
JP (1) JP2711759B2 (https=)
KR (1) KR0149029B1 (https=)
CA (1) CA2054017A1 (https=)
DE (1) DE69128760T2 (https=)
ES (1) ES2113358T3 (https=)
TW (1) TW201690B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US5849762A (en) * 1997-07-14 1998-12-15 Adolor Corporation Peripherally acting anti-pruritic opiates
US6353004B1 (en) 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物
US6365152B1 (en) 2001-03-15 2002-04-02 Bovine Health Products, Inc. Scours treatment and method of making same
FR2845600B1 (fr) * 2002-10-09 2005-07-08 Innovations Pharma Ag Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte
KR20050001548A (ko) * 2003-06-25 2005-01-07 동화약품공업주식회사 항설사용 약제학적 조성물
EP2131811B1 (fr) * 2007-03-14 2020-03-04 Vetinnov Produit appétent
FR2913601B1 (fr) * 2007-03-14 2009-10-30 Vetinnov Sarl Support appetent a formule amelioree
ITRM20120341A1 (it) 2012-07-17 2014-01-18 Er La Salute Della Donna E Del Bambino Soluzione glucosalina di mantenimento per la somministrazione parenterale ad uso pediatrico
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
CN104546736A (zh) * 2014-12-25 2015-04-29 北京科源创欣科技有限公司 小儿盐酸洛哌丁胺颗粒及其制备工艺
JP7459458B2 (ja) * 2018-06-28 2024-04-02 ライオン株式会社 内服組成物及びその製造方法
CN111450050A (zh) * 2019-01-22 2020-07-28 北京万全德众医药生物技术有限公司 盐酸洛哌丁胺口服溶液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571011B2 (en) * 1983-10-07 1988-03-31 State Of Victoria, The Treatment of neonatal calf diarrhoea
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4824853A (en) * 1985-10-11 1989-04-25 Janssen Pharmaceutica N.V. α,α-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides and method of treating diarrhea
JPS62138147A (ja) * 1985-12-12 1987-06-20 Snow Brand Milk Prod Co Ltd ガラクトオリゴ糖類配合飼料
JP2831004B2 (ja) * 1988-09-29 1998-12-02 大日本製薬株式会社 粉粒状医薬製剤
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
US5219573A (en) * 1989-10-17 1993-06-15 Hershey Foods Corporation L-sugar laxatives
NZ235876A (en) * 1989-11-01 1992-06-25 Mcneil Ppc Inc Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物

Also Published As

Publication number Publication date
JP2711759B2 (ja) 1998-02-10
EP0482580B1 (en) 1998-01-21
US5182112A (en) 1993-01-26
EP0482580A1 (en) 1992-04-29
KR0149029B1 (ko) 1998-10-15
DE69128760D1 (de) 1998-02-26
US5348744A (en) 1994-09-20
JPH04159223A (ja) 1992-06-02
KR920007627A (ko) 1992-05-27
TW201690B (https=) 1993-03-11
ES2113358T3 (es) 1998-05-01
DE69128760T2 (de) 1998-04-30

Similar Documents

Publication Publication Date Title
CA2054017A1 (en) Antidiarrheal compositions
US20040234593A1 (en) Diphenhydramine tannate compositions and methods of use
KR20210137046A (ko) 담즙정체의 치료 방법
EP0315960B1 (en) Instant oral-release capsule containing nifedipine
KR960011772B1 (ko) 개선된 디데옥시 퓨린 뉴클레오사이드 경구 투여 제제
JPS591412A (ja) 脳血管不全症処置用固形製剤
AU2019259791B2 (en) Liquid oral pharmaceutical dosage form
JPS62178514A (ja) 眼局所投与用眼圧降下剤
JPH08512322A (ja) Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物
JPH1036269A (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
EP0750500A1 (en) Treatment of diabetic nephropathy with valsartan
DE60018186T2 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
WO1995001780A1 (en) H2 antagonist-alginate combinations
NO784357L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
CA1300024C (en) Agent having renal function-improving effect and diuretic effect
EP1084706B1 (en) Use of simethicone to treat ulcerative colitis
US7074773B2 (en) Pharmaceutical composition for diabetic neuropathy
WO2003086346A1 (en) Diphenhydramine tannate compositions and methods of use
WO2016114734A1 (en) Pharmaceutical formulation of trimebutine maleate and simethicone comprising acidifying agent
EP0777470A1 (en) Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists
RU2336076C2 (ru) Пероральное лекарственное средство для восполнения дефицита магния в организме
IE44117B1 (en) Pharmaceutical compositions having diuretic and antihypertensive activity
EA012264B1 (ru) Фармацевтические композиции, основанные на антагонистах nk2, для применения в педиатрической практике
JPH0132804B2 (https=)
JPH04279524A (ja) 脳血管疾患治療剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued